Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticles

Impact of IL-10 Promoter Polymorphisms and IL-10 Serum Levels on Advanced Laryngeal Squamous Cell Carcinoma and Survival Rate

AGNE PASVENSKAITE, RASA LIUTKEVICIENE, GRETA GEDVILAITE, ALVITA VILKEVICIUTE, VYKINTAS LIUTKEVICIUS and VIRGILIJUS ULOZA
Cancer Genomics & Proteomics January 2021, 18 (1) 53-65; DOI: https://doi.org/10.21873/cgp.20241
AGNE PASVENSKAITE
1Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: agne.pasvenskaite{at}lsmuni.lt
RASA LIUTKEVICIENE
2Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GRETA GEDVILAITE
2Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALVITA VILKEVICIUTE
2Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VYKINTAS LIUTKEVICIUS
1Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VIRGILIJUS ULOZA
1Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 18 no. 1 53-65
DOI 
https://doi.org/10.21873/cgp.20241
PMID 
33419896

Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received November 16, 2020
  • Revision received December 2, 2020
  • Accepted December 17, 2020
  • Published online January 8, 2021.

Copyright & License 
Copyright © 2021 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. AGNE PASVENSKAITE1⇑,
  2. RASA LIUTKEVICIENE2,
  3. GRETA GEDVILAITE2,
  4. ALVITA VILKEVICIUTE2,
  5. VYKINTAS LIUTKEVICIUS1 and
  6. VIRGILIJUS ULOZA1
  1. 1Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania;
  2. 2Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania
  1. Correspondence to: Agne Pasvenskaite, Department of Otorhinolaryngology, Eivenių 2, LT-50009, Kaunas, Lithuania. Tel: +370 65323034, e-mail: agne.pasvenskaite{at}lsmuni.lt
View Full Text

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Cancer Genomics & Proteomics
Vol. 18, Issue 1
January-February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of IL-10 Promoter Polymorphisms and IL-10 Serum Levels on Advanced Laryngeal Squamous Cell Carcinoma and Survival Rate
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Impact of IL-10 Promoter Polymorphisms and IL-10 Serum Levels on Advanced Laryngeal Squamous Cell Carcinoma and Survival Rate
AGNE PASVENSKAITE, RASA LIUTKEVICIENE, GRETA GEDVILAITE, ALVITA VILKEVICIUTE, VYKINTAS LIUTKEVICIUS, VIRGILIJUS ULOZA
Cancer Genomics & Proteomics Jan 2021, 18 (1) 53-65; DOI: 10.21873/cgp.20241

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Impact of IL-10 Promoter Polymorphisms and IL-10 Serum Levels on Advanced Laryngeal Squamous Cell Carcinoma and Survival Rate
AGNE PASVENSKAITE, RASA LIUTKEVICIENE, GRETA GEDVILAITE, ALVITA VILKEVICIUTE, VYKINTAS LIUTKEVICIUS, VIRGILIJUS ULOZA
Cancer Genomics & Proteomics Jan 2021, 18 (1) 53-65; DOI: 10.21873/cgp.20241
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • CRISPR/Cas9-mediated Knockout of LYVE1 In Human Tongue Cancer Cells Reveals Transcriptomic Changes in Metastasis-associated Pathways
  • Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility
  • CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms
Show more Articles

Keywords

  • Laryngeal squamous cell carcinoma
  • IL-10
  • rs1800871
  • rs1800872
  • rs1800896
  • gene polymorphism
  • serum
  • levels
  • survival rate.
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire